Indian drugmaker Dr Reddy's signed an exclusive licensing pact with Australia's Immutep to develop and distribute the latter's cancer therapy, the companies said on Monday. As part of the agreement, ...

The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

A TOR-targeting cancer drug unexpectedly extends yeast lifespan through a newly discovered metabolic feedback loop.

A new federal negotiation round reshapes how your most expensive diabetes and cancer treatments will be priced under Medicare ...

Receiving anticancer immunotherapy earlier in the day may help individuals with cancer live longer. That's according to a ...

Food and Drug Administration Commissioner Marty Makary is under renewed scrutiny by Trump officials amid continued turmoil at ...

The government has approved new reimbursement rules enabling patients with advanced non-small cell lung cancer (NSCLC) to use ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

The Mikaela Naylon Give Kids a Chance Act now heads to the Senate, aiming to fast-track treatments and give children with ...

In what researchers are calling a ”breakthrough hiding in plain sight,” scientists have redesigned a 40-year-old deworming ...

Dr Reddy''s and Immutep collaborate to develop and commercialize Eftilagimod Alfa (Efti), a cancer medication, outside key ...

Dr Reddy’s has signed an exclusive licensing pact with Australia’s Immutep to develop and distribute the latter’s cancer ...